BPG is committed to discovery and dissemination of knowledge
Retrospective Study Open Access
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123356
Published online Nov 15, 2026. doi: 10.4251/wjgo.123356
Prognostic impact of lesser curvature lymph node count in stage I/II gastric cancer: A retrospective study
Pei-Feng Chen, Jia-Jun Qian, Lei Zhang, Zhang-Ming Chen, Department of Gastrointestinal and Hernia Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China
Wen-Xiu Han, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China
ORCID number: Zhang-Ming Chen (0000-0002-4830-0745); Wen-Xiu Han (0000-0002-5335-9645).
Co-first authors: Pei-Feng Chen and Jia-Jun Qian.
Co-corresponding authors: Zhang-Ming Chen and Wen-Xiu Han.
Author contributions: Chen PF and Qian JJ performed the study design, data collection, statistical analysis, manuscript drafting, and they contributed equally to this manuscript and are co-first authors; Zhang L participated in data interpretation and manuscript revision; Chen ZM provided funding support and participated in study supervision and manuscript revision; Han WX provided overall supervision of the study and final approval of the manuscript; Chen ZM and Han WX contributed equally to this manuscript and are co-corresponding authors. All authors have read and approved the final manuscript.
AI contribution statement: Portions of this manuscript were edited using DeepSeek for language refinement. The authors carefully reviewed and verified all AI-assisted outputs and take full responsibility for the scientific content of the manuscript.
Supported by Natural Science Research Project of Universities in Anhui Province, No. 2023AH053317.
Institutional review board statement: This retrospective study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University (Approval No. PJ 2024-11-66).
Informed consent statement: The requirement for informed consent was waived due to the retrospective nature of the study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Corresponding author: Wen-Xiu Han, PhD, Chief Physician, Professor, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Avenue, Shushan District, Hefei 230022, Anhui Province, China. yfy104613@fy.ahmu.edu.cn
Received: May 18, 2026
Revised: July 4, 2026
Accepted: September 8, 2026
Published online: November 15, 2026
Processing time: 173 Days and 23 Hours

Abstract
BACKGROUND

Current lymph node (LN) staging for gastric cancer relies primarily on total LN count. The number of LNs retrieved from specific anatomical regions may carry additional prognostic value.

AIM

To evaluate the prognostic impact of the lesser curvature LN count in patients with clinical stage I/II gastric cancer.

METHODS

A total of 254 patients with clinical stage I/II lesser curvature gastric adenocarcinoma who underwent curative total gastrectomy with D2 lymphadenectomy were retrospectively analyzed. The optimal cutoff was identified using a systematic threshold-searching approach based on the log-rank test and univariate Cox regression. This threshold was further assessed in key pathological subgroups and evaluated in multivariate Cox models adjusted for established prognostic factors.

RESULTS

The retrieval of ≤ 7 lesser curvature LNs was identified as the optimal cutoff, independently associated with worse overall survival (hazard ratio = 2.37, 95% confidence interval: 1.44-3.90, P = 0.0005). This prognostic significance was consistently validated in key subgroups including node-negative (N0), node-positive (N+), and T3 patients. In multivariate analysis, ≤ 7 lesser curvature LNs remained an independent adverse prognostic factor after adjusting for age, T stage, N stage, lymphovascular invasion, and perineural invasion (hazard ratio = 2.20, 95% confidence interval: 1.27-3.82, P = 0.005).

CONCLUSION

In this study, a lesser curvature LN count of ≤ 7 was associated with poorer overall survival, suggesting a potential risk of stage migration.

Key Words: Gastric cancer; Lymph node retrieval; Lesser curvature lymph node; Stage migration; Survival analysis

Core Tip: Current gastric cancer staging guidelines emphasize total lymph node (LN) count but may overlook the anatomical distribution of nodal metastases. This exploratory study investigated the prognostic impact of the lesser curvature LN count in 254 patients with stage I/II lesser curvature gastric cancer who underwent total gastrectomy. The retrieval of ≤ 7 lesser curvature LNs (stations 1, 3, 5, 7, 8, and 9) was independently associated with significantly poorer overall survival after adjusting for established prognostic factors. This region-specific threshold offers a potential anatomical complement to total LN count standards.



INTRODUCTION

Gastric cancer (GC) remains a major global health burden, ranking fifth in both incidence and mortality worldwide[1]. Although significant progress has been made in diagnosis and treatment in recent years, the fiveyear survival rate remains unsatisfactory[2]. Accurate staging is fundamental for formulating appropriate treatment strategies and predicting patient prognosis. Lymph node (LN) status represents a critical component of the tumor-node-metastasis (TNM) staging system for GC[3].

The adequacy of LN evaluation directly affects stage accuracy. For accurate N staging in gastric adenocarcinoma, the 8th edition American Joint Committee on Cancer (AJCC) guidelines recommend the pathological assessment of at least 16 regional LNs. Furthermore, several studies have proposed exploratory modifications to the AJCC staging criteria. For instance, Jia et al[4] and Zhang et al[5] replaced the absolute number of positive LNs with the LN ratio to construct revised staging systems, while Erstad et al[6] identified ≥ 30 examined LNs as the optimal threshold for minimizing stage migration. However, these modifications remain predominantly based on the total number of LNs retrieved, rather than focusing on the LN count from specific anatomical compartments.

Although lymphatic metastasis in GC can exhibit a diffuse pattern, a clear propensity for metastasis based on the primary tumor location is well-recognized[7,8]. According to the Japanese Classification of GC, the left gastric artery pathway represents the primary lymphatic drainage route from the lesser curvature of the stomach. Along this pathway, stations 1 (right paracardial), 3 (lesser curvature), and 5 (suprapyloric) constitute the perigastric tier, while stations 7 (left gastric artery), 8 (common hepatic artery), and 9 (celiac trunk) form the extra-perigastric tier; all six stations are included in the standard D2 lymphadenectomy field. Prior studies have demonstrated that metastatic involvement among stations along this pathway shows a high degree of synergistic correlation[9], and stations 1, 3, 7, and 9 have been grouped together as a functional left gastric artery nodal basin, with station 9 skip metastasis also linked to this pathway[10]. In clinical practice, these stations are routinely dissected en bloc during total gastrectomy and are frequently reported as a composite group in routine pathology. In this study, we uniformly refer to these as the “lesser curvature LNs”. This composite assessment reflects the physiological continuity of the dominant left gastric artery pathway and real-world pathological reporting practices.

The present study focuses on patients with clinically staged I/II GC located along the lesser curvature, as this cohort most directly aligns with the core issue of stage migration. In stage III/IV GC, where LN metastasis is prevalent, insufficient LN examination is unlikely to alter the fundamental N stage[11]. In contrast, patients with stage I/II tumors are more susceptible to potential misclassification - from true N+ to false N0 - due to inadequate retrieval, which may consequently compromise prognostic assessment and treatment decisions.

This exploratory study aimed to investigate whether the number of retrieved lesser curvature LNs is associated with prognosis in patients with clinical stage I/II GC, and to identify a potential cutoff that warrants further validation in larger, multicenter cohorts.

MATERIALS AND METHODS
Patients

In this study, the data of 3079 patients who underwent surgical treatment for GC in the First Affiliated Hospital of Anhui Medical University from November 2018 to December 2021 were collected. Previous studies have shown that LN retrieval is significantly higher in total gastrectomy than in distal gastrectomy[12,13]. As station 1 LNs were not consistently documented in distal gastrectomy specimens as per discussion with the Department of Pathology, only patients who underwent total gastrectomy were included to ensure complete assessment of the lesser curvature LNs. Inclusion criteria were as follows: (1) Patients with histologically confirmed primary gastric adenocarcinoma; (2) Tumor located predominantly along the lesser curvature of the stomach; (3) Underwent curative-intent total gastrectomy with D2 lymphadenectomy - this criterion was applied as station 1 LN are not consistently documented in distal gastrectomy specimens, and total gastrectomy ensures complete assessment of the lesser curvature lymphatic drainage region; (4) Clinically staged as stage I or stage II according to the 8th edition AJCC TNM staging system prior to surgery; and (5) Availability of complete clinicopathological data and follow-up information. Exclusion criteria were as follows: (1) Patients who received neoadjuvant chemotherapy or radiotherapy prior to surgery; (2) Presence of distant metastasis (M1) at diagnosis or during surgery; (3) History of other malignant tumors; and (4) Incomplete clinical, pathological, or survival data. After screening, we finally obtained the data of 254 patients who met these criteria (Figure 1). This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University (Approval No. PJ 2024-11-66).

Figure 1
Figure 1 Flow chart of patient selection process. TNM: Tumor-node-metastasis; LN: Lymph node.
Clinicopathological parameters

The clinicopathological data collected for all enrolled patients included age, sex, body mass index, tumor size, histological differentiation grade, presence of lymphovascular invasion, presence of perineural invasion, pathological T stage, pathological N stage, preoperative serum levels of carcinoembryonic antigen and carbohydrate antigen 19-9, as well as history of smoking and alcohol consumption. Lymphovascular invasion was defined as the presence of tumor cells within endothelial-lined lymphatic or vascular spaces on hematoxylin and eosin staining. Perineural invasion was defined as tumor cells infiltrating the perineurium or neural fascicles. Tumor location was classified according to the Japanese GC Association standard, which divides the stomach into three anatomical regions: Upper third (U), middle third (M), and lower third (L) based on the trisected points of the lesser and greater curvatures. For tumors spanning multiple regions, the segment containing the largest proportion of the tumor mass was used for classification.

The total number of LNs retrieved from stations 1, 3, 5, 7, 8, and 9 was uniformly recorded as the lesser curvature LN count. Due to the retrospective nature of this study and the variability in pathological reporting practices, individual station-level counts were not consistently available. In clinical practice, these stations are often dissected en bloc during total gastrectomy, and in many centers are reported as a composite group in routine pathology. Although individual station-level counts were not consistently available in this retrospective study, this composite assessment reflects real-world pathological reporting practices while retaining anatomical relevance. Postoperative information for all patients was collected through regular follow-up via outpatient clinic visits and telephone interviews. Overall survival (OS) was calculated from the date of surgery to the date of death from any cause or the last confirmed follow-up.

Statistical analysis

All statistical analyses were performed using R software (version 4.5.1). A P < 0.05 was considered statistically significant. Although patients were enrolled based on clinical stage I/II, subsequent subgroup analyses were performed using pathological T stage and N stage to provide the accurate postoperative risk stratification. Continuous variables were compared using the t-test or Mann-Whitney U test, as appropriate; categorical variables were compared using the χ2 test. Survival curves were estimated by the Kaplan-Meier method and compared with the log-rank test. An optimal prognostic cutoff for lesser curvature LN count was explored by testing all candidate cutoff points between the 20th percentiles and 80th percentiles. For each cutoff, survival differences were assessed by the log-rank test, and hazard ratios (HRs) were derived from univariate Cox regression. The cutoff yielding the most significant survival difference and highest HR was identified. Although patients were enrolled based on clinical stage I/II, subsequent subgroup analyses were performed using pathological T stage and N stage to provide the accurate postoperative risk stratification.

To examine whether the prognostic effect of the 7-node cutoff differed between T1/T2 and T3 subgroups, an interaction term (≤ 7 vs > 7 × T1/T2 vs T3) was introduced into a univariate Cox regression model. Post-hoc power analysis was conducted to determine the statistical power of the T1/T2 subgroup to detect the effect size observed in the fully adjusted overall cohort. The correlation between the lesser curvature LN count and the total LN count was assessed using Spearman’s rank correlation coefficient. Multivariate Cox proportional hazards regression analysis was performed to identify independent prognostic factors for OS. Two models were constructed to assess whether region-specific nodal assessment provides independent prognostic information beyond the global nodal count. Model 1 included age, T stage, N stage, differentiation grade, lymphovascular invasion, perineural invasion, and lesser curvature LN count; model 2 additionally included total LN count to assess whether region-specific nodal assessment provides independent prognostic information beyond the global nodal count. Time-dependent receiver operating characteristic analysis was used to evaluate the discriminatory ability of the ≤ 7 threshold for OS at 12 months, 36 months, and 60 months.

RESULTS
Clinicopathological characteristics of the patients

A total of 254 eligible patients were included in this study. The cohort comprised 190 males (74.8%) and 64 females (25.2%; Table 1). According to pathological staging, 106 patients (41.7%) were classified as T1/T2 and 148 (58.3%) as T3; 169 patients (66.5%) were nodenegative (N0) and 85 (33.5%) were node-positive (N+). Using a systematic threshold-searching analysis (described below), we identified 7 as the optimal prognostic cutoff for the lesser curvature LN count. Based on this, 158 patients (62.2%) were classified as having a high retrieval count (> 7 nodes), while 96 (37.8%) had a low retrieval count (≤ 7 nodes; Figure 2). No statistically significant differences in baseline clinicopathological characteristics were observed between these two groups (all P > 0.05). The median follow-up period was 56 months (range: 5-83 months). During follow-up, 62 patients (24.3%) died.

Figure 2
Figure 2 Determination of the optimal cutoff for lesser curvature lymph node count and its prognostic validation. A: Systematic evaluation of survival differences across candidate cutoff values (5-14 retrieved lymph nodes). The primary Y-axis (left) represents the statistical significance of the log-rank test expressed as -log10(P-value). Higher values on the -log10(P-value) scale correspond to greater statistical significance. The secondary Y-axis (right) shows the corresponding hazard ratio and 95% confidence interval derived from univariate Cox regression analysis for each cutoff; B: Kaplan-Meier overall survival curves for the entire cohort stratified by the optimal cutoff (≤ 7 vs > 7 retrieved lesser curvature lymph nodes).
Table 1 Baseline clinicopathological characteristics of the study cohort (n = 254), n (%)/mean ± SD.

lesser curvature lymph node ≤ 7 (n = 96)
lesser curvature lymph node > 7 (n = 158)
P value
Age (year)0.670
    < 6538 (39.58)57 (36.08)
    ≥ 6558 (60.42)101 (63.92)
Sex0.615
    Female22 (22.92)42 (26.58)
    Male74 (77.08)116 (73.42)
Differentiation0.858
    Poor33 (34.38)50 (31.65)
    Moderate59 (61.46)99 (62.66)
    Well4 (4.17)9 (5.7)
T stage0.925
    T124 (25)40 (25.32)
    T217 (17.71)25 (15.82)
    T355 (57.29)93 (58.86)
N stage0.767
    N064 (66.67)105 (66.46)
    N126 (27.08)46 (29.11)
    N26 (6.25)7 (4.43)
TNM stage1.000
    I23 (23.96)37 (23.42)
    II73 (76.04)121 (76.58)
Perineural invasion1.000
    Yes57 (59.38)95 (60.13)
    No39 (40.63)63 (39.87)
Vascular invasion0.166
    Yes47 (48.96)62 (39.24)
    No49 (51.04)96 (60.76)
Tumor size (cm)3.99 ± 2.483.60 ± 1.730.511
Total LN count17.91 ± 5.3423.44 ± 6.94< 0.001
BMI (kg/m2)0.324
    < 2359 (61.46)108 (68.35)
    ≥ 2337 (38.54)50 (31.65)
Smoke0.623
    Yes25 (26.04)47 (29.75)
    No71 (73.96)111 (70.25)
Drink0.942
    Yes20 (20.83)31 (19.62)
    No76 (79.17)127 (80.38)
CEA (ng/mL)0.680
    < 580 (83.33)136 (86.08)
    ≥ 516 (16.67)22 (13.92)
CA199 (μg/mL)1.000
    < 2784 (87.5)138 (87.34)
    ≥ 2712 (12.5)20 (12.66)
Tumor location0.788
    Upper37 (38.54)55 (34.81)
    Middle31 (33.29)57 (36.08)
    Lower28 (29.17)46 (29.11)
Postoperative chemotherapy0.422
    Yes38 (39.58)72 (45.57)
    No58 (60.42)86 (54.43)
Determination and validation of the optimal prognostic cutoff for lesser curvature LN count

Systematic evaluation of potential cutoff values (5-14 LNs) identified 7 retrieved LNs as the optimal prognostic threshold. This cutoff yielded the most significant survival difference by log-rank test (P = 0.0005) and the highest HR by Cox regression analysis [HR = 2.37, 95% confidence interval (CI): 1.44-3.90; Figure 2A]. Kaplan-Meier survival analysis confirmed that patients with ≤ 7 retrieved LNs had significantly worse OS compared to those with > 7 retrieved nodes (Figure 2B).

Prognostic impact of clinicopathological factors

As summarized in Table 1 and illustrated in the corresponding survival curves (Figure 3), the presence of lymphovascular invasion, age (≥ 65 years vs < 65 years), pathological stage (II vs I), deeper tumor invasion (T3 vs T1/T2), and LN metastasis (N+ vs N0) were all identified as significant predictors of poorer OS (all P < 0.05). Although a clear trend toward separation was observed in the Kaplan-Meier curve for perineural invasion, this association did not reach statistical significance (P = 0.058).

Figure 3
Figure 3 Kaplan-Meier survival analysis of clinicopathological factors. A: Stratified by pathological stage (stage I vs stage II); B: Stratified by depth of tumor invasion (T1/T2 vs T3); C: Stratified by lymph node status (N0 vs N+); D: Stratified by age (< 65 years vs ≥ 65 years); E: Stratified by lymphovascular invasion status (negative vs positive); F: Stratified by perineural invasion status (negative vs positive).
Validation of the optimal cutoff in prognostic subgroups

To assess clinical applicability of the lesser curvature LN count ≤ 7 cutoff, we performed the same threshold-searching analysis within patient subgroups. Among all candidate cutoffs from 5 to 14 that reached statistical significance (log-rank P < 0.05) in patients with node-negative disease (N0), node-positive disease (N+), and those with deeper tumor invasion (T3), a cutoff of 7 LNs consistently corresponded to the greatest HR for poor prognosis (Figure 4). This consistent finding across biologically distinct subgroups confirms that a lesser curvature LN count of less than or equal to 7 is a clinically meaningful marker of poorer survival, independent of LN status or T stage.

Figure 4
Figure 4 Validation of the 7-lymph-node cutoff in subgroups. A-C: Systematic evaluation of candidate cutoffs (5-14 nodes) in the N0 (A), N+ (B), and T3 (C) subgroups. The red highlight indicates that 7 lymph nodes was the threshold with the greatest hazard ratio among significant cutoffs (log-rank P < 0.05) in each subgroup; D-F: Corresponding Kaplan-Meier survival curves stratified by the 7-node cutoff (≤ 7 vs > 7) within the same N0 (D), N+ (E), and T3 (F) subgroups.
Prognostic performance of the 7-node cutoff in the T1/T2 subgroup

In contrast to the findings in N0, N+, and T3 subgroups, no statistically significant cutoff was identified in the T1/T2 subgroup using the threshold-searching approach (all log-rank P ≥ 0.05; Figure 5A). Kaplan-Meier analysis further confirmed that the 7-node cutoff did not yield significant prognostic stratification in T1/T2 patients (Figure 5B). An interaction term between lesser curvature LN count (≤ 7 vs > 7) and T stage (T1/T2 vs T3) in the Cox regression model was not statistically significant (P = 0.080). Post-hoc power analysis revealed that the T1/T2 subgroup had 38.1% statistical power to detect the effect size observed in the fully adjusted overall cohort (HR = 2.23).

Figure 5
Figure 5 Analysis of the T1/T2 subgroup and prognostic validation for the lymph node count cutoff. A: Threshold-searching analysis evaluating cutoffs from 5 to 14 retrieved lymph nodes. No cutoff yielded a statistically significant survival difference (all log-rank P ≥ 0.05); B: Kaplan-Meier survival curve for the T1/T2 subgroup stratified by the 7-node cutoff (≤ 7 vs > 7), demonstrating no significant prognostic stratification.
Multivariate analysis of prognostic factors

Prior to multivariate modeling, the correlation between the lesser curvature LN count and the total LN count was assessed. Spearman correlation analysis revealed a moderate positive correlation between the two metrics (ρ = 0.51, P < 0.001). To determine whether the lesser curvature LN count carries independent prognostic value, two multivariate Cox regression models were constructed (Table 2). Model 1 included age, T stage, N stage, differentiation grade, lymphovascular invasion, perineural invasion, and lesser curvature LN count. Model 2 additionally included total LN count to test whether the regional count provides prognostic information beyond the global count.

Table 2 Multivariate Cox regression analysis of factors associated with overall survival.
VariableModel 1 (without total LN)
Model 2 (with total LN)
HR (95%CI)
P value
HR (95%CI)
P value
Age (≥ 65 vs < 65)1.76 (1.00-3.12)0.0511.70 (0.95-3.00)0.075
T stage (T3 vs T1/T2)1.83 (0.92-3.65)0.0831.78 (0.89-3.55)0.100
N stage (N+ vs N0)1.89 (1.00-3.54)0.0461.99 (1.05-3.75)0.034
LVI (yes vs no)1.03 (0.53-2.03)0.9211.00 (0.50-1.96)0.969
PNI (yes vs no)0.84 (0.40-1.78)0.7680.90 (0.42-1.92)0.677
Differentiation (poor vs moderate/high)1.40 (0.3-2.36)0.2101.43 (0.85-2.42)0.180
Lesser curvature LN (≤ 7 vs > 7)2.49 (1.50-4.14)< 0.0012.20 (1.27-3.82)0.005
Total LN (< 16 vs ≥ 16)1.46 (0.79-2.72)0.228

On multivariate analysis, age ≥ 65 years, N+ stage, and lesser curvature LN count ≤ 7 were independently associated with worse OS in model 1. After further adjustment for total LN count (< 16 vs ≥ 16) in model 2, lesser curvature LN count ≤ 7 remained an independent adverse prognostic factor (HR = 2.20, 95%CI: 1.27-3.82, P = 0.005), whereas total LN count itself was not significant (HR = 1.46, 95%CI: 0.79-2.72, P = 0.228). Time-dependent receiver operating characteristic analysis using the ≤ 7 threshold as a binary classifier yielded areas under the curve of 0.73 (12 months), 0.68 (36 months), and 0.65 (60 months), indicating moderate and consistent discriminatory performance for OS.

DISCUSSION

In this single-center study of 254 patients with clinical stage I/II GC located in the lesser curvature, we found that the retrieval of ≤ 7 lesser curvature LNs (comprising stations 1, 3, 5, 7, 8, and 9) was associated with significantly worse OS. Notably, within this same cohort, the established AJCC benchmark of 16 total LNs was also validated as a significant prognostic cutoff (P = 0.0074, HR = 2.09, 95%CI: 1.21-3.61), confirming the reliability of our study population. Importantly, multivariate analysis confirmed that lesser curvature LN count ≤ 7 was an independent prognostic factor after adjusting for age, T stage, N stage, differentiation grade, lymphovascular invasion, perineural invasion, and total LN count. Of note, in the fully adjusted model, only N stage and lesser curvature LN count remained statistically significant, whereas age, T stage, differentiation grade, lymphovascular invasion, perineural invasion, and total LN count did not reach statistical significance. This finding provides robust statistical evidence that region-specific nodal assessment offers additive prognostic information compared with the global nodal count alone in this patient population. In tumors arising from specific gastric subsites such as the lesser curvature, the thoroughness of nodal dissection from the corresponding high-risk drainage area could carry important prognostic implications beyond the total LN count alone[14].

Subgroup analyses showed that a retrieved count of ≤ 7 lesser curvature LNs consistently conferred the highest HR for poor prognosis in patients with N0, N+, or T3 disease. Notably, the ≤ 7 threshold yielded the highest HR in the T3 subgroup (HR = 3.20; Figure 4C), where the tumor burden is greater. For patients with T3 or node-positive disease, thorough lymphatic evaluation is vital for preventing stage migration[15]. However, no statistically significant cutoff was identified within the T1/T2 subgroup (Figure 5). The non-significant interaction between the 7-node threshold and T stage (P = 0.080) suggests that its prognostic effect does not substantially differ between T1/T2 and T3 patients, and the post-hoc power of only 38.1% indicates that the negative finding in T1/T2 is most likely a type II error rather than evidence of a true absence of prognostic value. This may be compounded by the inherently lower incidence of lymphatic metastasis and fewer events in T1/T2 tumors, which further reduce the capacity of LN count threshold to demonstrate statistical significance in this subgroup[16]. Although the 7-node threshold has demonstrated prognostic value in the overall cohort and in key subgroups, its utility in T1/T2 tumors remains unconfirmed. We suggest that the 7-node threshold may serve as a reference for the adequacy of regional lymphadenectomy, while acknowledging that its prognostic value is more clearly established in patients with a higher tumor burden and requires further validation in larger, multicenter cohorts.

We next examined the potential factors that may influence the lesser curvature LN count. The LN node yield is a composite metric affected by both patient/tumor biology and technical aspects of surgery and pathology. From a biological perspective, factors such as microsatellite instability-high status, younger patient age, female sex, and lower body mass index have been associated with higher LN counts, potentially due to more pronounced immune responses or less challenging anatomy[17-20]. From a technical standpoint, while early reports suggested that laparoscopic surgery might yield fewer LNs compared to open gastrectomy, possibly due to the initial learning curve and differences in dissection scope[21], more recent, high-quality comparative studies have demonstrated that laparoscopic and open approaches achieve equivalent retrieval counts[22]. The determining factors have, therefore, shifted to the individual surgeon’s technique and the thoroughness of pathological examination rather than the surgical approach per se. Notably, immediate ex vivo LN dissection and sorting by the surgeon post-resection can significantly increase nodal yield compared to standard pathological assessment alone[23].

This study also confirmed that lymphovascular invasion and age ≥ 65 years are significantly associated with poor prognosis, consistent with extensive prior reports[24,25]. Although these factors are not yet incorporated into the TNM staging system, they may carry additive prognostic value when considered together with an insufficient retrieval of lesser curvature LNs (≤ 7 nodes). For patients with pathological stage I/II disease, a postoperative pathology report showing ≤ 7 lesser curvature LNs, particularly when accompanied by other established risk factors - such as lymphovascular invasion, perineural invasion, T3 stage, or age ≥ 65 years - should prompt careful consideration of individualized postoperative strategies.

This study has several limitations. First, it is a single-center, retrospective exploratory analysis; therefore, selection bias arising from single-center surgical practices, pathological testing standards, and patient admission characteristics cannot be ruled out. In particular, owing to the heterogeneity of pathological reporting practices across institutions, especially the inconsistent documentation of individual LN stations, a planned multicenter validation could not be conducted, and the generalizability of the findings to other institutions remain unverified. Second, the study cohort was restricted to patients who underwent total gastrectomy, excluding those who received distal gastrectomy or neoadjuvant therapy. Although this design choice was necessary to ensure complete anatomical coverage of the lesser curvature lymphatic drainage region, it inevitably limits the applicability of the results to the broader stage I/II GC population. Establishing standardized protocols for station-specific LN assessment and reporting would therefore be an essential step toward increasing the pool of usable cases for future multicenter validation.

CONCLUSION

In this single-center exploratory analysis, the retrieval of ≤ 7 lesser curvature LNs was associated with poorer OS in patients with stage I/II GC. This finding, while requiring prospective multicenter validation, suggests that region-specific nodal assessment may offer prognostic value beyond total LN counts.

ACKNOWLEDGEMENTS

The authors would like to thank the Department of Pathology, the First Affiliated Hospital of Anhui Medical University, for their assistance in reviewing LN station documentation and pathological reporting practices. We also thank all patients and their families whose data contributed to this study.

References
1.  Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-263.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 16785]  [Cited by in RCA: 18106]  [Article Influence: 9053.0]  [Reference Citation Analysis (55)]
2.  Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635-648.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 4042]  [Cited by in RCA: 3680]  [Article Influence: 613.3]  [Reference Citation Analysis (26)]
3.  Li GZ, Doherty GM, Wang J. Surgical Management of Gastric Cancer: A Review. JAMA Surg. 2022;157:446-454.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 230]  [Cited by in RCA: 229]  [Article Influence: 57.3]  [Reference Citation Analysis (9)]
4.  Jia G, Zhou D, Tang X, Liu J, Lei P. Prognostic value of a modified pathological staging system for gastric cancer based on the number of retrieved lymph nodes and metastatic lymph node ratio. PeerJ. 2024;12:e18165.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 8]  [Cited by in RCA: 6]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
5.  Zhang M, Ding C, Xu L, Ou B, Feng S, Wang G, Wang W, Liang Y, Chen Y, Zhou Z, Qiu H. Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer. Front Oncol. 2021;11:595421.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 14]  [Cited by in RCA: 20]  [Article Influence: 4.0]  [Reference Citation Analysis (7)]
6.  Erstad DJ, Blum M, Estrella JS, Das P, Minsky BD, Ajani JA, Mansfield PF, Ikoma N, Badgwell BD. Navigating Nodal Metrics for Node-Positive Gastric Cancer in the United States: An NCDB-Based Study and Validation of AJCC Guidelines. J Natl Compr Canc Netw. 2021;1-12.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 6]  [Cited by in RCA: 12]  [Article Influence: 2.4]  [Reference Citation Analysis (1)]
7.  Ma W, Guo H, Yang P, He J, Li T, Wu H, Wu J, Yang J, Tian Y, Guo S, Wang G, Wang H, Wang Q, Er L, Ding P, Zhao Q. Lymph node metastasis mapping and prognostic analysis of early gastric cancer. J Gastrointest Surg. 2025;29:102082.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (2)]
8.  de Jongh C, Triemstra L, van der Veen A, Brosens LAA, Luyer MDP, Stoot JHMB, Ruurda JP, van Hillegersberg R; LOGICA Study Group. Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial. Gastric Cancer. 2022;25:1060-1072.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 28]  [Cited by in RCA: 31]  [Article Influence: 7.8]  [Reference Citation Analysis (14)]
9.  Junfeng Z, Yingxue H, Peiwu Y. Systematic review of risk factors for metastasis to para-aortic lymph nodes in gastric cancer. Surg Oncol. 2013;22:210-216.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 6]  [Cited by in RCA: 8]  [Article Influence: 0.6]  [Reference Citation Analysis (5)]
10.  Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Yamada K, Sano T, Yamaguchi T. Investigation of the lymphatic stream of the stomach in gastric cancer with solitary lymph node metastasis. World J Surg. 2009;33:1235-1239.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 29]  [Cited by in RCA: 39]  [Article Influence: 2.3]  [Reference Citation Analysis (2)]
11.  de Jong MHS, Gisbertz SS, van Berge Henegouwen MI, Draaisma WA. Prevalence of nodal metastases in the individual lymph node stations for different T-stages in gastric cancer: a systematic review. Updates Surg. 2023;75:281-290.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 13]  [Article Influence: 4.3]  [Reference Citation Analysis (5)]
12.  Lu J, Wang W, Zheng CH, Fang C, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Huang CM, Zhou ZW. Influence of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: An Analysis From a Two-Institution Database in China. Ann Surg Oncol. 2017;24:486-493.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 67]  [Cited by in RCA: 73]  [Article Influence: 8.1]  [Reference Citation Analysis (7)]
13.  Li Z, Ji G, Bai B, Yu D, Liu Y, Lian B, Zhao Q. Laparoscopy-assisted distal gastrectomy versus laparoscopy-assisted total gastrectomy with D2 lymph node dissection for middle-third advanced gastric cancer. Surg Endosc. 2018;32:2255-2262.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 14]  [Cited by in RCA: 21]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
14.  Brisinda G, Chiarello MM, Fico V, Puccioni C, Crocco A, Bianchi V, Vanella S. Pattern of Distribution of Lymph Node Metastases in Individual Stations in Middle and Lower Gastric Carcinoma. Cancers (Basel). 2023;15:2139.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 9]  [Cited by in RCA: 13]  [Article Influence: 4.3]  [Reference Citation Analysis (2)]
15.  Jannasch O, Schwanz M, Otto R, Mik M, Lippert H, Mroczkowski P. Lymph Node Yield and Lymph Node Ratio for Prognosis of Long-Term Survival in Gastric Carcinoma. Cancers (Basel). 2025;17:414.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 4]  [Cited by in RCA: 11]  [Article Influence: 11.0]  [Reference Citation Analysis (2)]
16.  Liu Y, Zhou C, Gan L, Zhang Q, Chang J, Wang X, Wang X, Xu M, Chen J, Sheng W, Liu F. Finding the minimum number of retrieved lymph nodes and negative lymph nodes in gastric cancer surgery: a real-world study. Int J Surg. 2024;110:5574-5584.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 6]  [Reference Citation Analysis (1)]
17.  Cai Z, Song H, Fingerhut A, Sun J, Ma J, Zhang L, Li S, Yu C, Zheng M, Zang L. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer. BMC Cancer. 2021;21:319.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 1]  [Cited by in RCA: 6]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
18.  Morgan JW, Ji L, Friedman G, Senthil M, Dyke C, Lum SS. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. JAMA Surg. 2015;150:37-43.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 50]  [Cited by in RCA: 64]  [Article Influence: 5.8]  [Reference Citation Analysis (1)]
19.  Dikken JL, van Grieken NC, Krijnen P, Gönen M, Tang LH, Cats A, Verheij M, Brennan MF, van de Velde CJ, Coit DG. Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. Eur J Surg Oncol. 2012;38:319-325.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 14]  [Cited by in RCA: 17]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
20.  Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, Ito K, Akiyama S, Nakao A. Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology. 2004;51:1225-1228.  [PubMed]  [DOI]
21.  Bouras G, Lee SW, Nomura E, Tokuhara T, Tsunemi S, Tanigawa N. Comparative analysis of station-specific lymph node yield in laparoscopic and open distal gastrectomy for early gastric cancer. Surg Laparosc Endosc Percutan Tech. 2011;21:424-428.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 12]  [Cited by in RCA: 12]  [Article Influence: 0.8]  [Reference Citation Analysis (1)]
22.  Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Yu J, Zheng C, Liu F, Li Z, Zhao G, Zhang J, Chen P, Li G; Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial. JAMA Surg. 2022;157:9-17.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 214]  [Cited by in RCA: 225]  [Article Influence: 56.3]  [Reference Citation Analysis (11)]
23.  Hanna GB, Amygdalos I, Ni M, Boshier PR, Mikhail S, Lloyd J, Goldin R. Improving the standard of lymph node retrieval after gastric cancer surgery. Histopathology. 2013;63:316-324.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 30]  [Cited by in RCA: 32]  [Article Influence: 2.5]  [Reference Citation Analysis (2)]
24.  Li Z, Li X, Guan S, Zhu G, Lin H, Wu H, Jia J, Guo Z, Cai Z, Zheng Q, Zhang H, Ruan F, Zheng X, Yang C, Xu Y, Ye J. Correlation Analysis Between Tumor Deposit and Clinicopathologic Characteristics and Prognosis of Gastric Cancer: A Multicenter Retrospective Study. Ann Surg Oncol. 2024;31:5984-5996.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 10]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
25.  Choi S, Song JH, Lee S, Cho M, Kim YM, Kim HI, Hyung WJ. Lymphovascular Invasion: Traditional but Vital and Sensible Prognostic Factor in Early Gastric Cancer. Ann Surg Oncol. 2021;28:8928-8935.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 39]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
Footnotes

Peer review: Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Oncology

Country of origin: China

Peer-review report’s classification

Scientific quality: Grade B, Grade B, Grade B, Grade C

Novelty: Grade B, Grade B, Grade B, Grade B

Creativity or innovation: Grade B, Grade B, Grade B, Grade C

Scientific significance: Grade B, Grade B, Grade B, Grade B

P-Reviewer: Li J, Chief Physician, MD, China; You R, Associate Chief Physician, China; Zhou X, Assistant Professor, Deputy Director, Vice Director, China S-Editor: Zuo Q L-Editor: A P-Editor: Zhang YL

Write to the Help Desk